Nuo Therapeutics (AURX) Cash & Equivalents (2010 - 2026)
Nuo Therapeutics (AURX) posted Cash & Equivalents of $449,325 for Q2 2026, up 42.0% from $316,354 a year earlier.
Powered by 
Analysis
Nuo Therapeutics (AURX) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Nuo Therapeutics' Cash & Equivalents came in at $548,946, up 93.5% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 27.7% (FY2020 to FY2025).
- In prior years, Nuo Therapeutics' Cash & Equivalents was $283,714 in FY2024 (-69.4%), $928,681 in FY2023 (-54.7%), $2.05 million in FY2022 (+45.0%) and $1.41 million in FY2021 (+776.3%).
- Quarterly Cash & Equivalents has run from a low of $55,655 in Q1 2025 to a high of $3.44 million in Q2 2022 over five years.
- On a year-over-year basis, Cash & Equivalents increased in three of the last seven quarters, with an average decline of 8.5%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2021, with growth of 776.3%; the weakest was Q2 2023, with a decline of 90.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.71 Bn | 229.74 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 178.38 Bn | 148.81 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 161.61 Bn | 145.42 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 154.15 Bn | 134.44 Bn | 2.08 Bn | 2.98 Bn |
| 5 | Medtronic | 123.21 Bn | 88.46 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 117.50 Bn | 103.61 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 67.50 Bn | 62.26 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Becton Dickinson | 54.80 Bn | 51.95 Bn | 2.32 Bn | 708.00 Mn |
| 9 | Edwards Lifesciences | 51.78 Bn | 35.79 Bn | 1.35 Bn | 2.91 Bn |
| 10 | Nuo Therapeutics | 60.54 Mn | 58.71 Mn | 1.17 Mn | 449,325.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 449,325.00 |
| Dec 31, 2025 | 548,946.00 |
| Sep 30, 2025 | 514,797.00 |
| Jun 30, 2025 | 316,354.00 |
| Mar 31, 2025 | 55,655.00 |
| Dec 31, 2024 | 283,714.00 |
| Sep 30, 2024 | 683,836.00 |
| Jun 30, 2024 | 473,040.00 |
| Mar 31, 2024 | 366,232.00 |
| Dec 31, 2023 | 928,681.00 |
| Sep 30, 2023 | 582,589.00 |
| Jun 30, 2023 | 344,371.00 |
| Mar 31, 2023 | 1.25 Mn |
| Dec 31, 2022 | 2.05 Mn |
| Sep 30, 2022 | 2.88 Mn |
| Jun 30, 2022 | 3.44 Mn |
| Mar 31, 2022 | 665,391.00 |
| Dec 31, 2021 | 1.41 Mn |
| Sep 30, 2021 | 148,430.00 |
| Jun 30, 2021 | 151,585.00 |
API Access
Nuo Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AURX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AURX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AURX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();